STOCK TITAN

MENS Stock Price, News & Analysis

MENS Nasdaq

Welcome to our dedicated page for MENS news (Ticker: MENS), a resource for investors and traders seeking the latest updates and insights on MENS stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect MENS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of MENS's position in the market.

Rhea-AI Summary
Jyong Biotech Ltd., a Taiwan-based biotechnology company focused on plant-derived drugs for urinary system diseases, has announced the pricing of its IPO on the Nasdaq Global Market under the symbol MENS. The company is offering 2,666,667 ordinary shares at $7.50 per share, aiming to raise $20 million in gross proceeds. Trading will commence on June 17, 2025, with an additional over-allotment option of 400,000 shares. The proceeds will primarily fund Phase III trials of MCS-2 (40%), earlier phase trials (25%), Phase II trial of PCP (10%), Phase I trial of IC (5%), and general corporate purposes (20%). Joseph Stone Capital is serving as the sole underwriter for this firm commitment offering.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags

FAQ

What is the current stock price of MENS (MENS)?

The current stock price of MENS (MENS) is $10.11 as of June 17, 2025.
MENS

Nasdaq:MENS

MENS Rankings

MENS Stock Data